Breast Cancer Research
The clinical research activity is centered on breast cancer, with a specific focus on HER2-positive early breast cancer and the assessment of treatment response in the neoadjuvant setting. The sponsor’s trial interest lies in identifying approaches that support the prediction of pathological complete response after systemic therapy.
- HER2-positive early breast cancer
- Pathological complete response
- Neoadjuvant chemotherapy
Research activity includes interest in molecular imaging and radiotracer-based evaluation linked to tumor response in breast oncology.
Oncologic Imaging
The sponsor is involved in imaging-based oncology research aimed at improving response prediction in HER2-targeted disease. This includes work related to tumor-specific radiotracers and their use in characterizing treatment-sensitive disease.
- Molecular imaging
- HER2-targeted assessment
- Treatment response prediction
The research profile reflects a clinical interest in non-invasive assessment of disease behavior in breast cancer.
